TheraRadar
← Back
Data updated: Mar 29, 2026

NEW HEIGHTSRX

CardiovascularOphthalmologyInfectious Disease
Generics

NEW HEIGHTSRX is a generic drug manufacturer focused on Cardiovascular, Ophthalmology, Infectious Disease.

1995
Since
4
Drugs
-
Trials
37
Approved (2yr)

Key Drugs

No active drugs

Top Drug Revenues Pro

Loading...

Revenue Over Time Pro

Loading...

Recent Activity

CIPROFLOXACIN HYDROCHLORIDE 2025-12-17
Labeling
CIPROFLOXACIN HYDROCHLORIDE 2025-09-30
Labeling
CIPROFLOXACIN HYDROCHLORIDE 2025-09-30
Labeling
CIPROFLOXACIN HYDROCHLORIDE 2025-09-30
Labeling
CIPROFLOXACIN HYDROCHLORIDE 2025-09-30
Labeling
CIPROFLOXACIN HYDROCHLORIDE 2025-09-30
Labeling
CIPROFLOXACIN HYDROCHLORIDE 2025-09-30
Labeling
CIPROFLOXACIN HYDROCHLORIDE 2025-09-30
Labeling
SEC Filings Pro
Loading...

Therapeutic Areas

Score weights: Approved drugs ×3, Phase 3 ×2, Phase 2 ×1, Phase 1 ×0.5

Cardiovascular 25%
1 drugs
Ophthalmology 25%
1 drugs
Infectious Disease 25%
1 drugs
Dermatology 25%
1 drugs

Pipeline Forecast

Loading...

Upcoming Trial Milestones Pro

Loading...

Patent Cliff Pro

Loading...

Competitors by Therapeutic Area

Baxter specialty
Infectious Disease, Cardiovascular, Dermatology, Ophthalmology
B BRAUN specialty
Infectious Disease, Ophthalmology, Dermatology, Cardiovascular
BAUSCH AND LOMB specialty
Ophthalmology, Cardiovascular, Infectious Disease, Dermatology
FOUGERA PHARMS other
Dermatology, Ophthalmology, Infectious Disease, Cardiovascular
Bayer big-pharma
Cardiovascular, Ophthalmology, Dermatology